A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Systemic Sclerosis
Related studies linked through entity extraction aliases.
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)
- Status
- COMPLETED
- Phase
- NA
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis
- Status
- WITHDRAWN
- Phase
- NA
Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- N/A
Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- PHASE3
Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)
- Status
- WITHDRAWN
- Phase
- NA
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
- Status
- TERMINATED
- Phase
- NA
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
- Status
- TERMINATED
- Phase
- NA
Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
- Status
- COMPLETED
- Phase
- NA
EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS
- Status
- UNKNOWN
- Phase
- NA
Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis
- Status
- UNKNOWN
- Phase
- N/A
Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Lower Urinary Tract Symptoms in Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- NA
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
- Status
- COMPLETED
- Phase
- PHASE2